NOS2 and cerebral malaria: In experimental cerebral malaria, it was found to suppress the production of IL-1β (19) and in Mycobacterium infection; it exerts its anti-inflammatory activity by reducing the expression of both the IL-1β and inducible nitric oxide synthase (20).